Global push for precision health risks widening inequities without systemic, cultural, and resource reforms
Original framing: “[Comment] The Lancet Commission on precision health: equitable, data-driven health outcomes for all” — The Lancet
Voices from low‑resource settings, women’s health collectives, and disability advocacy groups consistently flag the danger of algorithmic bias and unaffordable therapies. Their testimonies highlight the need for transparent consent processes, equitable pricing, and co‑design of precision tools that reflect lived realities rather than abstract risk scores.
The Lancet Commission’s precision health agenda, while scientifically promising, reproduces historic patterns of data colonialism unless it is reframed through Indigenous stewardship, cross‑cultural hybrid models, and robust social‑determinant integration.
By embedding community‑led governance, equitable financing, and ethical AI oversight, the initiative can shift from a technology‑centric narrative to a systemic transformation that acknowledges past injustices and anticipates future inequities. Actors ranging from WHO, national ministries, biotech firms, and grassroots health collectives must coordinate to redesign data pipelines, ensure benefit‑sharing, and co‑create platforms that reflect the lived realities of marginalised populations. Historical precedents such as the HIV activism of the 1990s demonstrate that coordinated, rights‑based advocacy can redirect biomedical innovation toward universal health justice.